Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Timothy Ashby

Concepts (195)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
36
2024
2929
2.680
 Why?
High-Throughput Nucleotide Sequencing
7
2022
169
1.220
 Why?
Genomics
10
2023
286
0.890
 Why?
Mutation
14
2022
1294
0.890
 Why?
Software
4
2021
273
0.880
 Why?
Clonal Evolution
4
2020
56
0.600
 Why?
Plasma Cells
6
2023
223
0.590
 Why?
Computational Biology
4
2020
214
0.570
 Why?
Algorithms
4
2020
615
0.520
 Why?
Neoplasm Recurrence, Local
5
2024
614
0.490
 Why?
Tumor Microenvironment
3
2024
212
0.430
 Why?
Neoplasms
2
2020
1235
0.420
 Why?
Translocation, Genetic
7
2022
264
0.420
 Why?
Monoclonal Gammopathy of Undetermined Significance
2
2023
103
0.410
 Why?
Hematopoietic Stem Cell Transplantation
3
2024
565
0.400
 Why?
Osteolysis
2
2022
75
0.400
 Why?
Models, Molecular
1
2013
338
0.400
 Why?
Humans
44
2024
49974
0.390
 Why?
Gene Expression Profiling
9
2023
1032
0.370
 Why?
Genome, Human
3
2021
111
0.370
 Why?
Chromosome Aberrations
3
2023
297
0.370
 Why?
Evolution, Molecular
2
2021
99
0.360
 Why?
Gene Expression Regulation, Neoplastic
5
2024
828
0.360
 Why?
Proteins
1
2013
342
0.350
 Why?
Prognosis
11
2024
1942
0.350
 Why?
Bone Marrow
3
2020
362
0.330
 Why?
Epigenomics
2
2021
67
0.320
 Why?
Antineoplastic Combined Chemotherapy Protocols
4
2020
989
0.280
 Why?
Disease Progression
7
2023
825
0.250
 Why?
Gene Rearrangement
2
2023
74
0.250
 Why?
Oncogenes
3
2021
57
0.250
 Why?
Chemokine CXCL12
1
2024
32
0.240
 Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2023
10
0.220
 Why?
Burkitt Lymphoma
1
2023
28
0.220
 Why?
Gene Dosage
2
2020
78
0.210
 Why?
Epigenesis, Genetic
3
2023
374
0.210
 Why?
Proto-Oncogene Proteins c-akt
1
2023
157
0.210
 Why?
Signal Transduction
3
2024
1618
0.210
 Why?
Drug Resistance, Neoplasm
1
2024
308
0.210
 Why?
Proto-Oncogene Proteins B-raf
2
2020
79
0.200
 Why?
Neoplasm Proteins
2
2021
322
0.200
 Why?
Cell Communication
1
2022
69
0.200
 Why?
Telomere Homeostasis
1
2021
10
0.190
 Why?
Ubiquitination
1
2021
43
0.190
 Why?
Polycomb Repressive Complex 2
1
2021
47
0.190
 Why?
Chromosome Deletion
2
2023
140
0.190
 Why?
Loss of Heterozygosity
2
2018
77
0.190
 Why?
Lymphoma, B-Cell
1
2021
63
0.190
 Why?
Positron-Emission Tomography
2
2022
295
0.190
 Why?
Genes, Tumor Suppressor
2
2021
73
0.180
 Why?
Sequence Analysis, DNA
2
2018
237
0.180
 Why?
B-Lymphocytes
1
2021
170
0.180
 Why?
Cell Cycle
1
2021
231
0.180
 Why?
Cell Cycle Proteins
1
2021
166
0.180
 Why?
Lymphoma, Follicular
1
2020
27
0.180
 Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.180
 Why?
Leukemia, Plasma Cell
1
2020
33
0.180
 Why?
Bone Resorption
1
2022
304
0.170
 Why?
Gene Regulatory Networks
1
2020
107
0.170
 Why?
Osteocytes
1
2022
207
0.170
 Why?
Genes, myc
1
2019
40
0.170
 Why?
Mice
7
2024
5739
0.170
 Why?
Tumor Suppressor Protein p53
2
2017
202
0.160
 Why?
Transplantation, Autologous
4
2024
466
0.160
 Why?
Mutagenesis
1
2018
60
0.160
 Why?
Diffusion Magnetic Resonance Imaging
1
2018
123
0.150
 Why?
Genome
1
2018
65
0.150
 Why?
Neoplasm, Residual
1
2018
165
0.150
 Why?
Homologous Recombination
1
2018
40
0.150
 Why?
Chromosomes, Human, Pair 17
1
2017
36
0.140
 Why?
Survival Rate
4
2021
894
0.140
 Why?
Transcriptome
2
2020
315
0.140
 Why?
DNA Repair
1
2018
193
0.140
 Why?
Flow Cytometry
1
2018
476
0.130
 Why?
Female
10
2021
26472
0.130
 Why?
Cell Line, Tumor
3
2024
1403
0.130
 Why?
DNA Copy Number Variations
3
2022
110
0.130
 Why?
Aged
8
2021
9310
0.130
 Why?
Aged, 80 and over
5
2021
3129
0.130
 Why?
Remission Induction
3
2021
207
0.130
 Why?
Genes, Neoplasm
1
2015
30
0.130
 Why?
Pattern Recognition, Automated
1
2015
42
0.120
 Why?
Middle Aged
8
2021
12069
0.120
 Why?
Cluster Analysis
1
2015
235
0.120
 Why?
Animals
7
2024
13187
0.120
 Why?
Follow-Up Studies
4
2021
2182
0.120
 Why?
Databases, Protein
1
2013
29
0.110
 Why?
Protein Structure, Secondary
1
2013
72
0.110
 Why?
Sequence Alignment
1
2013
121
0.110
 Why?
Male
10
2021
25241
0.110
 Why?
Amino Acid Sequence
1
2013
585
0.100
 Why?
Chromatin
2
2023
151
0.100
 Why?
T-Lymphocytes
2
2024
338
0.100
 Why?
Adenocarcinoma
1
2015
396
0.090
 Why?
Breast Neoplasms
1
2020
1174
0.090
 Why?
Mutation Rate
2
2021
36
0.090
 Why?
In Situ Hybridization, Fluorescence
2
2023
259
0.090
 Why?
Tumor Burden
2
2020
132
0.090
 Why?
Alleles
2
2021
250
0.090
 Why?
Adult
6
2021
13236
0.090
 Why?
Clone Cells
2
2021
74
0.090
 Why?
Proto-Oncogene Proteins p21(ras)
2
2021
66
0.080
 Why?
Lung Neoplasms
1
2015
606
0.080
 Why?
DNA, Neoplasm
2
2020
147
0.080
 Why?
Histones
2
2021
312
0.080
 Why?
DNA Mutational Analysis
2
2020
175
0.080
 Why?
Treatment Outcome
4
2020
5141
0.080
 Why?
DNA Methylation
2
2023
548
0.070
 Why?
Recurrence
2
2021
652
0.070
 Why?
Genomic Instability
2
2018
92
0.070
 Why?
Risk Factors
3
2021
3613
0.070
 Why?
Cell Proliferation
2
2021
1007
0.060
 Why?
Internet
2
2018
259
0.060
 Why?
Ferritins
1
2024
30
0.060
 Why?
Myeloid Progenitor Cells
1
2023
18
0.060
 Why?
Xenograft Model Antitumor Assays
1
2024
211
0.060
 Why?
Antibodies
1
2024
154
0.060
 Why?
Proteasome Inhibitors
1
2024
104
0.060
 Why?
Integrin beta Chains
1
2023
14
0.050
 Why?
Integrins
1
2023
31
0.050
 Why?
Oxidative Phosphorylation
1
2023
39
0.050
 Why?
B-Cell Maturation Antigen
1
2024
90
0.050
 Why?
Cytogenetic Analysis
1
2023
82
0.050
 Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
 Why?
Cystatin M
1
2022
20
0.050
 Why?
Chromosomes, Human, Pair 1
1
2023
93
0.050
 Why?
Immunoglobulins
1
2023
79
0.050
 Why?
Forkhead Transcription Factors
1
2023
112
0.050
 Why?
Phylogeny
1
2022
235
0.050
 Why?
Syndecan-1
1
2021
72
0.050
 Why?
Spliceosomes
1
2021
10
0.050
 Why?
RANK Ligand
1
2022
179
0.050
 Why?
Transcriptional Activation
1
2021
121
0.050
 Why?
RNA Splicing
1
2021
37
0.050
 Why?
Alternative Splicing
1
2021
56
0.050
 Why?
Cyclin D2
1
2020
20
0.050
 Why?
Aneuploidy
1
2020
16
0.050
 Why?
Spatio-Temporal Analysis
1
2020
10
0.050
 Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.050
 Why?
Chromosomes, Human, Pair 4
1
2020
31
0.050
 Why?
Gene Expression Regulation, Leukemic
1
2020
33
0.050
 Why?
Chromosomes, Human, Pair 11
1
2020
54
0.050
 Why?
Histone Code
1
2020
32
0.050
 Why?
Cyclin D1
1
2020
56
0.050
 Why?
ras Proteins
1
2020
64
0.050
 Why?
Ecosystem
1
2021
64
0.050
 Why?
Phosphoproteins
1
2021
107
0.050
 Why?
Chromosomes, Human, Pair 14
1
2020
75
0.050
 Why?
Single-Cell Analysis
1
2020
57
0.040
 Why?
Mice, Transgenic
1
2021
555
0.040
 Why?
Protein Disulfide-Isomerases
1
2019
14
0.040
 Why?
Cell Differentiation
1
2022
651
0.040
 Why?
Genes, Immunoglobulin Heavy Chain
1
2019
13
0.040
 Why?
DNA
1
2023
541
0.040
 Why?
Genetic Variation
1
2020
213
0.040
 Why?
Melphalan
1
2020
174
0.040
 Why?
Neoplasm Invasiveness
1
2020
267
0.040
 Why?
Osteoclasts
1
2022
425
0.040
 Why?
Multivariate Analysis
1
2021
577
0.040
 Why?
Osteogenesis
1
2022
352
0.040
 Why?
Combined Modality Therapy
1
2021
637
0.040
 Why?
Maintenance Chemotherapy
1
2019
49
0.040
 Why?
Disease Models, Animal
1
2024
1455
0.040
 Why?
Apoptosis
1
2024
1101
0.040
 Why?
Cell Survival
1
2020
600
0.040
 Why?
Promoter Regions, Genetic
1
2020
475
0.040
 Why?
25-Hydroxyvitamin D3 1-alpha-Hydroxylase
1
2017
8
0.040
 Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2017
27
0.040
 Why?
Genome-Wide Association Study
1
2018
166
0.040
 Why?
Information Dissemination
1
2018
79
0.040
 Why?
STAT3 Transcription Factor
1
2017
81
0.040
 Why?
Fibroblast Growth Factors
1
2017
47
0.040
 Why?
Reproducibility of Results
1
2021
1193
0.040
 Why?
Mitogen-Activated Protein Kinases
1
2017
155
0.040
 Why?
Prospective Studies
1
2023
2364
0.040
 Why?
Dose-Response Relationship, Drug
1
2020
1376
0.040
 Why?
Proportional Hazards Models
1
2018
402
0.030
 Why?
Genes, ras
1
2016
43
0.030
 Why?
Thalidomide
1
2019
377
0.030
 Why?
Kaplan-Meier Estimate
1
2018
466
0.030
 Why?
Genes, p53
1
2016
51
0.030
 Why?
Cohort Studies
1
2020
1422
0.030
 Why?
Models, Genetic
1
2016
170
0.030
 Why?
Antineoplastic Agents
1
2024
1171
0.030
 Why?
Phosphatidylinositol 3-Kinases
1
2016
141
0.030
 Why?
Survival Analysis
1
2017
653
0.030
 Why?
Stem Cell Transplantation
1
2016
181
0.030
 Why?
Dogs
1
2015
182
0.030
 Why?
Databases, Genetic
1
2015
88
0.030
 Why?
Sequence Analysis, RNA
1
2015
91
0.030
 Why?
Time Factors
1
2021
2903
0.030
 Why?
Genetic Testing
1
2015
119
0.030
 Why?
Longitudinal Studies
1
2016
688
0.030
 Why?
Retrospective Studies
1
2024
6108
0.030
 Why?
Child
1
2023
6847
0.020
 Why?
Ashby's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (195) concept(s)
_
Co-Authors Expand Description
See all (26) people
_
Similar People Expand Description
See all (34) people
_
Same Department Expand Description
Search Department